P.L. Lollini, Commentary on "High throughput views of cancer immune responsiveness" by Wang et al., «ENHANCER», 2005, 3, pp. 20 - 20 [Abstract]
Spadaro M; Ambrosino E; Iezzi M; Di Carlo E; Sacchetti P; Curcio C; Amici A; Wei WZ; Musiani P; Lollini PL; Cavallo F; Forni G., Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity., «CLINICAL CANCER RESEARCH», 2005, 11, pp. 1941 - 1952 [Scientific article]
Croci S; Strippoli P; Bonsi L; Bagnara GP; Guizzunti G; Sartini R; Tonelli R; Messina C; Pierdomenico L; Lollini PL., Expression of T cell receptor alpha gene (TCRA) in human rhabdomyosarcoma and other musculo-skeletal sarcomas., «GENE», 2005, 353, pp. 16 - 22 [Scientific article]
Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL., Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma., «THE AMERICAN JOURNAL OF PATHOLOGY», 2005, 166, pp. 1205 - 1216 [Scientific article]
Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; Cavallo F; Calogero RA., Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario., «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2005, 54, pp. 599 - 610 [Scientific article]
P.L. Lollini, Immune response to tumor, in: H.W. VOHR, Encyclopedic reference of immunotoxicology, HEIDELBERG, Springer, 2005, pp. 670 - 674 [Dictionary or encyclopedia entry]
Pappalardo F; Lollini PL; Castiglione F; Motta S., Modeling and simulation of cancer immunoprevention vaccine., «BIOINFORMATICS», 2005, 21, pp. 2891 - 2897 [Scientific article]
S. Motta; F. Castiglione; P.-L. Lollini; F. Pappalardo, Modelling vaccination schedules for a cancer immunoprevention vaccine., «IMMUNOME RESEARCH», 2005, 1, pp. 1 - 18 [Scientific article]
Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P., New target antigens for cancer immunoprevention, «CURRENT CANCER DRUG TARGETS», 2005, 5, pp. 221 - 228 [Scientific article]
P.-L. Lollini, Terapia genica, in: Le biotecnologie e la qualità della vita, BOLOGNA, Patron Editore, 2005, pp. 129 - 138 [Chapter or essay]
Casadio F; Croci S; D'Errico Grigioni A; Corti B; Grigioni WF; Landuzzi L; Lollini PL., Toward the definition of immunosuppressive regimens with antitumor activity., «TRANSPLANTATION PROCEEDINGS», 2005, 37, pp. 2144 - 2147 [Scientific article]
Cuadros C; Dominguez AL; Lollini PL; Croft M; Mittler RS; Borgstrom P; Lustgarten J., Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice., «INTERNATIONAL JOURNAL OF CANCER», 2005, 116, pp. 934 - 943 [Scientific article]
Giavazzi R; Aglietta M; Astolfi A; Falanga A; Fusco A; Labianca R; Lollini PL; Lombardo C; Natali PG; Pierotti MA; Presta M; Santoro M; Taraboletti G; Zupi G; Vecchio G, 45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003, «TUMORI», 2004, 90, pp. 356 - 362 [Scientific article]
DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P. L., Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity., «INTERNATIONAL JOURNAL OF CANCER», 2004, 109, pp. 200 - 206 [Scientific article]
QUAGLINO E.; ROLLA S.; IEZZI M.; SPADARO M.; MUSIANI P.; DE GIOVANNI C.; LOLLINI P.L.; LANZARDO S.; FORNI G.; SANGES R.; CRISPI S.; DE LUCA P.; CALOGERO R.; CAVALLO F., Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions., «THE JOURNAL OF CLINICAL INVESTIGATION», 2004, 113, pp. 709 - 717 [Scientific article]
